{"id":"W2169154753","doi":"10.1016/j.bbmt.2014.12.010","title":"Comparison of Outcomes of Allogeneic Transplantation for Chronic Myeloid Leukemia with Cyclophosphamide in Combination with Intravenous Busulfan, Oral Busulfan, or Total Body Irradiation","year":2014,"lang":"en","type":"article","venue":"Biology of Blood and Marrow Transplantation","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; Office of Naval Research; National Heart, Lung, and Blood Institute; Seattle Genetics; CellGenix; Genentech; Health Resources and Services Administration; Swedish Orphan Biovitrum; Miltenyi Biotec; Kiadis Pharma; Therakos; Sigma-Tau Pharmaceuticals; Medical College of Wisconsin; Blue Cross and Blue Shield Association; Teva Pharmaceutical Industries; WellPoint; Celgene; Otsuka America Pharmaceutical; Amgen; Ariad Pharmaceuticals; GlaxoSmithKline; Terumo BCT; Leukemia and Lymphoma Society; Be The Match Foundation; U.S. Department of Health and Human Services; National Marrow Donor Program","keywords":"Busulfan; Medicine; Myeloid leukemia; Total body irradiation; Cyclophosphamide; Transplantation; Internal medicine; Oncology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001609871,0.0003118496,0.000519897,0.0004184778,0.0001314695,0.0004785697,0.0002617105,0.000328238,0.00056302],"category_scores_gemma":[0.002650878,0.0001030015,0.0009753064,0.0003525756,0.0002205395,0.000301773,0.0004391404,0.0005082021,0.0001209084],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003734905,"about_ca_system_score_gemma":0.000322753,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004531041,"about_ca_topic_score_gemma":0.0007389594,"domain_scores_codex":[0.9989648,0.0004939422,0.0001137269,0.0001337749,0.0001687043,0.000124984],"domain_scores_gemma":[0.9979227,0.0007396507,0.0008270264,0.0001027387,0.00008512856,0.0003227031],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03270619,0.0007305455,0.9263307,0.0002025976,0.002310704,0.0003883074,0.0001544353,0.001213761,0.002598759,0.0001533108,0.0003703619,0.03284032],"study_design_scores_gemma":[0.0009103186,0.01851687,0.9751432,0.00007483386,0.001313629,0.0007783895,0.000188528,0.001245354,0.0009434934,0.0001686356,0.0006987937,0.00001796532],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984889,0.001033987,0.00008682958,0.0000246176,0.000009573364,0.000009473785,0.00008043668,0.000002270558,0.000264043],"genre_scores_gemma":[0.9990883,0.0003968691,0.00003850278,0.00002313967,0.00003149057,0.00001081934,0.0003543749,0.000001730966,0.00005475966],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001609871,"threshold_uncertainty_score":0.008513927,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01141582798629627,"score_gpt":0.2715707441943132,"score_spread":0.2601549162080169,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}